611
SSGJ-611-CRS-II-01
Phase 3 small_molecule active
Quick answer
611 for Sinusitis is a Phase 3 program (small_molecule) at Sunshine Biopharma with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Sunshine Biopharma
- Indication
- Sinusitis
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active